155 related articles for article (PubMed ID: 819667)
1. Vaccine against human hepatitis B.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
JAMA; 1976 Jun; 235(26):2832-4. PubMed ID: 819667
[TBL] [Abstract][Full Text] [Related]
2. Development and chimpanzee testing of a vaccine against human hepatitis B.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293
[TBL] [Abstract][Full Text] [Related]
3. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
Tabor E; Barker LF; Gerety RJ
J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine.
Lelie PN; Reesink HW; Niessen J; Brotman B; Prince AM
J Med Virol; 1987 Nov; 23(3):289-95. PubMed ID: 2963091
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A and B: serologic survey of human and nonhuman primate sera.
Eichberg JW; Kalter SS
Lab Anim Sci; 1980 Jun; 30(3):541-3. PubMed ID: 6253744
[TBL] [Abstract][Full Text] [Related]
7. Immune adherence and complement-fixation tests for human hepatitis A. Diagnostic and epidemiologic investigations.
Hilleman MR; Provost PJ; Miller WJ; Villarejos VM; Ittensohn OL; McAleer WJ
Dev Biol Stand; 1975; 30():383-9. PubMed ID: 173600
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
Itoh Y; Takai E; Ohnuma H; Kitajima K; Tsuda F; Machida A; Mishiro S; Nakamura T; Miyakawa Y; Mayumi M
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9174-8. PubMed ID: 3466181
[TBL] [Abstract][Full Text] [Related]
10. Vaccine against human hepatitis B. 1976.
Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hillerman MR
JAMA; 1996 Dec; 276(22):1793-5. PubMed ID: 8946889
[No Abstract] [Full Text] [Related]
11. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
[TBL] [Abstract][Full Text] [Related]
12. Infectious patterns of Australia antigenemia and antibodies in chimpanzees.
Desmyter J; Liu WT; De Somer P; Mortelmans J
Prog Immunobiol Stand; 1971; 5():81-8. PubMed ID: 4633981
[No Abstract] [Full Text] [Related]
13. [What should a vaccine against hepatitis B be like?].
Anan'ev VA; Zhdanov VM
Vopr Virusol; 1978; (6):643-9. PubMed ID: 86238
[No Abstract] [Full Text] [Related]
14. Hepatitis B vaccine: current progress and strategies for utilization.
Maynard JE
Prog Clin Biol Res; 1980; 47():157-68. PubMed ID: 7208509
[No Abstract] [Full Text] [Related]
15. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.
Purcell RH; Gerin JL
Am J Med Sci; 1975; 270(2):395-9. PubMed ID: 828832
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis-B vaccine. Safety criteria and non-B infection.
Zuckerman AJ
Lancet; 1976 Jun; 1(7974):1396-7. PubMed ID: 59027
[No Abstract] [Full Text] [Related]
17. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.
Kamili S; Sozzi V; Thompson G; Campbell K; Walker CM; Locarnini S; Krawczynski K
Hepatology; 2009 May; 49(5):1483-91. PubMed ID: 19274751
[TBL] [Abstract][Full Text] [Related]
18. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
[TBL] [Abstract][Full Text] [Related]
19. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates.
Provost PJ; Conti PA; Giesa PA; Banker FS; Buynak EB; McAleer WJ; Hilleman MR
Proc Soc Exp Biol Med; 1983 Mar; 172(3):357-63. PubMed ID: 6302710
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.
Davis HL; McCluskie MJ; Gerin JL; Purcell RH
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7213-8. PubMed ID: 8692971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
